The recommended injection technique is the micro-puncture technique that involves injecting very small amounts of RESTYLANE® Vital into the deep dermis, about 1- 2cm apart. Once injected, the NASHA gel flows smoothly and distributes evenly in the skin.

The natural hydrating properties of RESTYLANE® Vital also make it well suited to all skin types, whether skin is dry or oily.

The RESTYLANE® range of products has a proven track record of safety with more than two million treatments across 70 countries, and FDA approval. RESTYLANE® Vital also obtained European CE certification in 2004 for the indication for hydration of the skin by injections.

Generic name

Non-Animal Stabilized Hyaluronic Acid (NASHA) gel.

RESTYLANE® Vital is made from Q-Med’s patented NASHA gel, with no extra additives.

By bacterial fermentation from streptococci bacteria.

No allergy test needed.

Hyaluronic acid is completely broken down within the skin over a period of months, eventually leaving no trace of the filler.

Licenced status

Medical device.

Should be used by

Restylane® Vital should be used by trained members of the medical profession only.

Product range

RESTYLANE® Vital Gel

RESTYLANE® Vital Light Gel

Unlike the rest of the RESTYLANE® range which have varying particle sizes suitable for different levels of correction by dermal filling, RESTYLANE® Vital is a smooth formulation without particles, which helps it distribute evenly and smoothly under the skin to aid rejuvenation.

RESTYLANE® Vital (20mg/ml of HA)is available in a pre-filled syringe of 1ml NASHA-gel, and each pack includes three needles, for greater patient injection comfort. It is administered using a 30G needle.

 

In late 2008, Q-Med launched a less-concentrated, finer particle version of RESTYLANE® Vital called RESTYLANE® Vital Light (12mg/ml of HA). 

 

It can be used for the same treatment as RESTYLANE® Vital but the manufacturer is recommending the use of the product as a preventative treatment for skin that it still in good condition, i.e. younger patients.

 

The product is available in a pack with a pre-filled 1ml syringe with three 30G needles or it can be delivered via a pen-style injector.

 

Each disposable injector comes preloaded with 2mls of product and also includes three needles. It will require manual winding by the practitioner before its trigger mechanism can be used to release a precise amount of product (10 µl) into the skin, meaning uniform injection and results.

 

(It is reported that this type of injector may be developed by Q-Med for use with other products within the RESTYLANE® range in the future).

Not to be used in

Individuals with a known hypersensitivity to hyaluronic acid.

RESTYLANE® Vital should not be used in or near areas where there is active skin disease, inflammation or related conditions.

RESTYLANE® Vital should not be injected into an area where a permanent implant has been placed.

Duration of effect

This depends upon your age and lifestyle as well as the correct placement of the product by a practitioner.

Generally, two to three treatments every fourth week are recommended initially, followed with maintenance treatments approximately every four to six months.

After the injection of RESTYLANE® Vital, some common injection related reactions might occur. These reactions include transient erythema (redness), swelling, pain, itching, discolouration or tenderness at the injection site. Typically resolution is spontaneous, within one or two days after injection into the skin.

Additionally, temporary palpable lumpiness has been noted after injection in some patients.

Localised reactions thought to be of a hypersensitivity nature have been reported in about 1 in every 10,000 treated patients. These have consisted of swelling at the injection. Redness, tenderness and rarely acneform papules may occur.

The reactions have started either shortly after injection or after a delay of 2-4 weeks and have generally been described as mild to moderate and self-limiting, with an average duration of 2 weeks.

In addition, rare cases (less than I in 15,000 treatments) of granuloma formation, superficial necrosis and urticaria have been reported.

Costs

This depends on the area treated and how much is required, and the practitioner doing the treatment, but price ranges are in the region of £175 per 1ml syringe of RESTYLANE® Vital or £500 for a course of three treatments, typically lasting up to 30 minutes. RESTYLANE® Vital Light is approximately £250 per 2ml syringe or £700 for a course of three treatments.

 

Clinical Results

 

 

Click here to find Clinics or Practitioners who offer Restylane® Vital treatment